An ocular form of myasthenia gravis with a high titer of anti-MuSK antibodies during a long-term follow-up

Internal Medicine

Volumn 51, Issue 21, 2012, Pages 3077-3079

  Hosaka, Ai ^a   Takuma, Hiroshi ^a   Ohta, Kiyoe ^b   Tamaoka, Akira ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UTANO NATIONAL HOSPITAL   (Japan)

Author keywords

Anti MuSK antibodies; Autoimmune disease; Long term; Myasthenia gravis; Ocular form

Indexed keywords

ATROPINE; EDROPHONIUM; MUSCLE SPECIFIC TYROSINE KINASE ANTIBODY; PREDNISOLONE; PROTEIN ANTIBODY; PYRIDOSTIGMINE; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; DIARRHEA; DIPLOPIA; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; ELECTROPHYSIOLOGY; FASCICULATION; FEMALE; FOLLOW UP; GAZE PARALYSIS; HUMAN; MYASTHENIA GRAVIS; NERVE STIMULATION; NEUROLOGIC EXAMINATION; OCULAR MYASTHENIA GRAVIS; ORBICULARIS OCULI MUSCLE; PTOSIS; RADIOIMMUNOASSAY;

ADULT; AUTOANTIBODIES; EYE DISEASES; FEMALE; HUMANS; MYASTHENIA GRAVIS; OPHTHALMOPLEGIA; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; TIME FACTORS;

EID: 84869105825     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.8196     Document Type: Article

References (12)

1. Lindstrom JM, Seybold ME, Lennon VA, Whittingham S, Duane DD. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology 26: 1054-1059, 1976.
2. Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8: 475-490, 2009.
3. McConville J, Farrugia ME, Beeson D, et al. Detection and char- acterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol 55: 580-584, 2004.
4. Sanders DB, El-Salem K, Massey JM, McConville J, Vincent A. Clinical aspects of MuSK antibody positive seronegative MG. Neurology 60: 1978-1980, 2003.
5. Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7: 365-368, 2001.
6. Ohta K, Shigemoto K, Fujinami A, Maruyama N, Konishi T, Ohta M. Clinical and experimental features of MuSK antibody positive MG in Japan. Eur J Neurol 14: 1029-1034, 2007.
7. Guptill JT, Sanders DB, Evoli A. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts. Muscle Nerve 44: 36-40, 2011.
8. Caress JB, Hunt CH, Batish SD. Anti-MuSK myasthenia gravis presenting with purely ocular findings. Arch Neurol 62: 1002-1003, 2005.
9. Bennett DL, Mills KR, Riordan-Eva P, Barnes PR, Rose MR. Anti-MuSK antibodies in a case of ocular myasthenia gravis. J Neurol Neurosurg Psychiatry 77: 564-565, 2006.
10. Hanisch F, Eger K, Zierz S. MuSK-antibody positive pure ocular myasthenia gravis. J Neurol 253: 659-660, 2006.
11. Chan JW, Orrison WW. Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular musclee atrophy. Br J Ophthalmol 91: 842-843, 2007.
12. Benatar M, Kaminski HJ. Evidence report: the medical treatment of ocular myasthenia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 68: 2144-2149, 2007.